BackAdagio Therapeutics Overview

Adagio Therapeutics Current Assets

Track Adagio Therapeutics's current assets ($200M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$204.91M
170.25% YoYΔ $129.09M vs prior year quarter

Peer average / median

Loading

Adagio Therapeutics Current Assets History

Loading

Adagio Therapeutics vs. peers: Current Assets Comparison

Loading

Adagio Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Adagio Therapeutics (ADGI) FAQ

As of the most recent data (March 2026), ADGI shows a current assets of $200M. That compares with $76M in the prior-year period — up 170.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADGI's current assets is now $200M (was $76M) — a 170.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Adagio Therapeutics is outperforming or lagging.

Tracking ADGI's current assets over time shows whether Adagio Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $76M in the prior-year period — up 170.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Adagio Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $200M) with ownership activity and broader fundamentals.

Adagio Therapeutics's current assets is $200M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.